US45826H1095 - Common Stock
INTEGER HOLDINGS CORP
NYSE:ITGR (5/6/2024, 7:08:24 PM)
After market: 111.73 0 (0%)111.73
+0.46 (+0.41%)
Integer Holdings Corp. engages in the manufacture and development of medical devices and components. The company is headquartered in Plano, Texas and currently employs 10,000 full-time employees. The company went IPO on 2000-09-29. The firm serves the cardiac rhythm management, neuromodulation, orthopedics, vascular, advanced surgical and portable medical markets. The company provides medical technologies worldwide. In addition, the Company develops batteries for applications in energy, military and environmental markets. Its brands include Greatbatch Medical, Lake Region Medical and Electrochem. The firm has two segments: Medical and Non-Medical. The Medical segment includes the cardio and vascular; cardiac rhythm management, and neuromodulation and advanced surgical; orthopedics and portable medical product lines. The Non-Medical segment comprises the Electrochem product line. Electrochem provides customized battery power and power management systems. Electrochem designs and manufactures customized primary (non-rechargeable) battery solutions, which are used in the energy, military and environmental markets.
INTEGER HOLDINGS CORP
5830 Granite Parkway., Suite 1150
Plano TEXAS 75024
P: 12146185243
CEO: Joseph W. Dziedzic
Employees: 10000
Website: https://integer.net
ITGR stock results show that Integer Holdings beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Integer Holdings (NYSE:ITGR) just reported results for the first quarter of 202...
~ Strong start to the year with 1Q24 financial results ~~ Reiterate 2024 financial outlook ~ PLANO, Texas, April 25, 2024 (GLOBE NEWSWIRE) --...
Among its other key ratings Dexcom has a near-best 98 Earnings Per Share Rating out of 99, reflecting strong profit growth this past year.
The Relative Strength (RS) Rating for Edwards Lifesciences stock jumped into a new percentile Tuesday, with a rise from 78 to 81.
On Monday, Tandem Diabetes Care stock received an upgrade to its Relative Strength (RS) Rating, from 68 to 78.
Here you can normally see the latest stock twits on ITGR, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: